Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plethico Of India To Reduce CRAMS Work, Citing Lower Margins

This article was originally published in PharmAsia News

Executive Summary

India's Plethico Pharmaceuticals, citing the nation's rising inflation and fuel costs, plans to reduce its contract research and manufacturing services. The firm's CFO said the higher costs and inflation are creating insufficient profit margins as it faces renegotiation of contracts. Plethico also faced added competition in the CRAMS business when Wockhardt entered that aspect of the industry last year. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068870

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel